I do take the Nov 15th PR as an indication they know their s/s is an issue. If The Doheny Group (TDG) would of demanded more commons when they bumped up funding to 2,200 units, the full ratchet on their guaranteed 9.99% position would of kicked in against them. The CEO would've been forced to increase the o/s to not only issue them shares, but to maintain control and meet the difference as well.
The o/s COULD of been destroyed and TDG share value could of decreased despite the increase in their position. I figure the bullet they dodged despite letting go roughly a 30% increase in their position, was a 25% increase in the o/s, the pps would of most definitely crashed.
I hope that PR and the SC-13G calculating the o/s at 16.9 million means they plan on doing something about it and are.
BTW, one company you mentioned should be going current this week... http://www.otcmarkets.com/stock/UAMM/filings
I'm a non-professional individual investor who may own, not own, buy, or sell stock at any given time in any security ever mentioned in posts. I never accept compensation in any form to post. Always consult an investment professional when investing.
Recent LTES News
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 05/06/2024 11:49:48 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/04/2024 01:07:11 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 12/28/2023 12:47:08 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 12:13:59 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/06/2023 06:06:55 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/15/2023 11:37:34 AM
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM